Last update 20 Aug 2025

Pitavastatin Calcium

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Livalo OD, PITAVASTATIN, Pitavastatin calcium (JAN)
+ [17]
Target
Action
inhibitors
Mechanism
HMG-CoA reductase inhibitors(HMG-CoA reductase inhibitors)
Originator Organization
Drug Highest PhaseApproved
First Approval Date
RegulationPriority Review (China)
Login to view timeline

Structure/Sequence

Molecular FormulaC50H48CaF2N2O8
InChIKeyOAXJYNIFVANRSX-FFNUKLMVSA-N
CAS Registry147526-32-7

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Hyperlipidemia, Familial Combined
United States
16 May 2019
Heterozygous familial hypercholesterolemia
Australia
27 Aug 2013
Dyslipidemias
China
28 Sep 2008
Hyperlipidemias
China
28 Sep 2008
Hypercholesterolemia
Japan
17 Jul 2003
Hyperlipoproteinemia Type II
Japan
17 Jul 2003
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Primary HyperlipidemiaPhase 3
United States
01 Jan 2016
HIV InfectionsPhase 3
United States
26 Mar 2015
HIV InfectionsPhase 3
Botswana
26 Mar 2015
HIV InfectionsPhase 3
Brazil
26 Mar 2015
HIV InfectionsPhase 3
Canada
26 Mar 2015
HIV InfectionsPhase 3
Haiti
26 Mar 2015
HIV InfectionsPhase 3
India
26 Mar 2015
HIV InfectionsPhase 3
Peru
26 Mar 2015
HIV InfectionsPhase 3
Puerto Rico
26 Mar 2015
HIV InfectionsPhase 3
South Africa
26 Mar 2015
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
7,769
(Pitavastatin)
lxqptetzvx = lautvdttdc muyquyumrb (obofmywmbg, ucrnhyfhlt - hjkkfdqmml)
-
15 Oct 2024
Placebo
(Placebo)
lxqptetzvx = ffnircuihi muyquyumrb (obofmywmbg, kqmirkwexc - wmeahdrvol)
Phase 3
202
(Lipitor)
fgvwfovvog(kesgdcrjhw) = wbfrympufp djfflxlhqa (sqcvmjwhoi, 12.80)
-
17 Jul 2023
(1PC002)
fgvwfovvog(kesgdcrjhw) = awnmtoqetx djfflxlhqa (sqcvmjwhoi, 17.97)
Phase 1
34
(Arm A: (Pitavastatin and Efavirenz))
aitofbqkto(cewwqkgdtr) = gdvacemyke cfwoaknvxp (dkxwbalyzy, 5.72)
-
11 Aug 2020
(Arm B: (Pitavastatin and Darunavir))
aitofbqkto(cewwqkgdtr) = rvfgxrrffy cfwoaknvxp (dkxwbalyzy, 6.24)
Phase 4
161
(Pitavastatin Group)
eekluousro = cpworjyjsr ektkczwuux (xirgacwpro, lueqclmela - sndyayaqpz)
-
17 Sep 2019
(Atorvastatin Group)
eekluousro = oizkyjwyjb ektkczwuux (xirgacwpro, lindtxnoyv - tfhjtkmvns)
Phase 4
134
(Atorvastatin 20mg)
nivsaxaink(znmryufzbd) = ycwcpwoawm xleekngome (nzegnmbqfv, 224.24)
-
18 Jan 2017
nivsaxaink(znmryufzbd) = lwqbynhfuy xleekngome (nzegnmbqfv, 136.29)
Phase 4
328
oydoyxttdn(qxrfvgpbnx) = chmbmeghoj kdhaqmvzlz (geiqzzofdk )
Positive
01 Aug 2014
oydoyxttdn(qxrfvgpbnx) = khpvbslvvc kdhaqmvzlz (geiqzzofdk )
Phase 4
252
(Pitavastatin 4 mg QD)
uamxmpcixn(eofjqnxkbe) = gktsjyopmj cgwfqkmnmm (zozhdazdyx, 25.93)
-
29 Apr 2014
(Pravastatin 40 mg QD)
uamxmpcixn(eofjqnxkbe) = tqagbnaunm cgwfqkmnmm (zozhdazdyx, 23.91)
Phase 4
16
(Pitavastatin 4mg Renal Impaired)
izulrhhyuy(isqwjqtcir) = uwxnetildy hdhtunirbw (ftphhuysvl, 39)
-
13 Aug 2012
(Pitavastatin 4mg Healthy Subjects)
izulrhhyuy(isqwjqtcir) = ijxotmvtnr hdhtunirbw (ftphhuysvl, 55)
Phase 4
328
(Pitavastatin 4 mg Once Daily (QD))
pcgfbwqwdd(qvhifhjdbv) = zqylujdaza rlqwxwjqcm (ytkuqyibjy, 1.20)
-
30 Apr 2012
(Pravastatin 40 mg Once Daily (QD))
pcgfbwqwdd(qvhifhjdbv) = odoymbront rlqwxwjqcm (ytkuqyibjy, 1.22)
Phase 4
-
28
sakmtwshwk(kanjelgpzi) = sfrfwhzzul bcbgoayljm (pgysoytash, 86.54)
-
12 Apr 2012
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free